Insights & Resources

Estimates of future outpatient surgery migration indicate that ASC industry revenue and profits will increase significantly. Find out why.

The NIST released guidance that includes rarely provided how-to instructions that will be helpful to organizations in monitoring telehealth risks.

You may have a fitness tracker that is connected to an application on your phone. The app sends data to a server that your primary care physician (PCP) can also access.

Get ahead of the curve by looking back at emerging trends in 2021 that are likely to impact health care valuation in 2022 and beyond.

Read about some of the impacts of increased hospital employment and accelerated retirements resulting in shortages of replacement physician investors.

The urgent care industry has been experiencing accelerated patient visit volume into 2021, continuing trends started in 2020.

Many business valuations begin with calculating a multiple of EBITDA (earnings before interest, taxes, depreciation, and amortization). In health care, however, valuators should deliberate just when and how to apply general valuation EBITDA transaction multiples for fair market value opinions.

Commentary from publicly traded Managed Care Organizations (MCOs) regarding their insurance spend expectations can be an excellent source of macroeconomic data for health care valuation professionals when projecting performance for provider entities.

Questions about the shelf life of a fair market value (FMV) opinion can arise when the parties seek certainty about compliance with government regulations or wish to maintain arrangements that are financially viable to all parties.

Professionals tasked with performing health care appraisals still face circumstantial challenges when performing their work fifteen months after the pandemic began. While a lot has changed, the basics of valuation have not.

NCAA member institutions are required to submit financial data detailing operating revenues and expenses related to its intercollegiate athletics program on or before January 15 after the end of the institution’s fiscal year.

Transactions for large hospice providers are yielding historically high multiples of EBITDA and revenue.